Release of Angiogenic Inhibitors for Macular Edema

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$100,000.00
Award Year:
2004
Program:
SBIR
Phase:
Phase I
Contract:
1R43EY015581-01
Agency Tracking Number:
EY015581
Solicitation Year:
2004
Solicitation Topic Code:
n/a
Solicitation Number:
PHS2004-2
Small Business Information
CHARLESSON, LLP
CHARLESSON, LLP, BOX 14103, OKLAHOMA CITY, OK, 73113
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
Y
Duns:
n/a
Principal Investigator:
YAN Feng
(405) 514-6372
YANFENGGOK@HOTMAIL.COM
Business Contact:
(405) 413-6290
Research Institution:
n/a
Abstract
DESCRIPTION (provided by applicant) Increased vascular permeability or vascular leakage in the retina is an early and common feature of diabetic retinopathy and can result in diabetic macular edema. Vascular leakage is also responsible for cystoid mac

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government